This Week in Neurology: Stroke Interventions and Alzheimer's Risk Factors

From the JAMA, a randomized trial examined adjunctive therapies for acute ischemic stroke. The authors describe how adding intra-arterial alteplase to thrombectomy increased excellent functional outcome rates at 90 days ^[1].

However, findings suggest this approach may also increase mortality, requiring careful risk-benefit assessment before implementation.

Elsewhere in the field of vascular health, a systematic review and meta-analysis evaluated nurse-driven service models for stroke care. The study included over 5725 patients with acute ischemic stroke to assess door-to-needle times ^[4].

Results indicate that these models can reduce this critical time metric by approximately 16 minutes.

In related research on inflammatory markers, a secondary analysis of thrombectomy outcomes explored the role of admission white blood cell counts. The authors describe how higher WBC levels associate with favorable effects from methylprednisolone after successful reperfusion ^[5].

This trial involved over 1200 patients with anterior-circulation large-vessel occlusion stroke.

Shifting focus to Alzheimer's disease risk factors, a meta-analysis examined the link between periodontal health and cognitive decline. Researchers identified an association where participants with gum disease showed higher odds of developing Alzheimer's ^[2].

Meanwhile, dietary interventions were also evaluated in community-dwelling adults over three years. The MIND diet demonstrated superior longitudinal outcomes compared to control diets among older adults with elevated amyloid-beta levels ^[3].